Progression-free survival | Overall survival | ||||||
---|---|---|---|---|---|---|---|
HR | 95 % CI | P | HR | 95 % CI | P | ||
Age | ≤60 years | 1 | |||||
>60 years | 1.484 | 0.969-2.272 | 0.070 | 1.236 | 0.770-1.984 | 0.379 | |
Smoking | Never | ||||||
Ever | 1.080 | 0.496-2.353 | 0.846 | 1.076 | 0.465-2.494 | 0.864 | |
Performance status | ECOG 0 | ||||||
ECOG 1-2 | 1.110 | 0.661-1.862 | 0.694 | 2.381 | 1.215-4.673 | 0.012 | |
Prior surgery | No | ||||||
Yes | 0.799 | 0.512-1.246 | 0.322 | 0.608 | 0.361-1.024 | 0.061 | |
Prior radiotherapy | No | ||||||
Yes | 0.924 | 0.555-1.541 | 0.763 | 0.741 | 0.398-1.379 | 0.345 | |
Prior chemotherapy | No | ||||||
Yes | 0.839 | 0.440-1.602 | 0.595 | 1.111 | 0.577-2.410 | 0.752 | |
No. of metastases | One | ||||||
≥Two | 1.181 | 0.777-1.795 | 0.436 | 1.698 | 1.059-2.717 | 0.028 | |
Lung metastasis | No | ||||||
Yes | 1.119 | 0.624-1.764 | 0.858 | 1.201 | 0.701-2.012 | 0.488 | |
Liver metastasis | No | ||||||
Yes | 1.235 | 0.650-2.347 | 0.520 | 1.397 | 0.497-1.838 | 0.544 | |
Treatment | CC | 0.219 | |||||
CP | 0.786 | 0.515-1.198 | 0.263 | 0.745 | 0.465-1.192 |